AI Summary
The Doctors Company has completed its purchase of ProAssurance for $25 per share, valuing the deal at roughly $1.3 billion. ProAssurance will deregister and delist from NYSE, with public trading ceasing. The combined insurer will serve more than 200,000 healthcare professionals and manage about $12 billion in assets.
Sentiment Rationale
The PRA equity will be delisted and converted to cash at $25; limited to no remaining liquidity or upside; historically, delistings following cash-out reduce price discovery and cap returns for remaining holders.
Trading Thesis
PRA is now a cash-out security with immediate delisting; exit now and redeploy capital.
Market-Moving
- PRA shareholders receive $25 per share in cash; total value ~ $1.3B.
- ProAssurance will delist; public trading ceases post-close.
- The Doctors Company becomes parent; combined assets reach $12B.
- Deal approved by PRA shareholders in June 2025; closing June 26, 2026.
Key Facts
- The Doctors Company completes ProAssurance acquisition for $25 per share.
- Total deal value about $1.3 billion; PRA to delist NYSE.
- Combined group to have $12 billion assets and 200k+ healthcare professionals.
- PRA shareholders approved in June 2025; public trading ceased.
Companies Mentioned
- The Doctors Company (Private): Acquirer; physician-owned insurer; privatized status; integration underway.
- ProAssurance Corporation (PRA): Acquired for $25 cash; to become wholly owned subsidiary; delisted from NYSE.
M&A
M&A: This is a large consolidation in medical professional liability, likely driving scale, pricing power, and underwriting efficiency for the combined entity; PRA holders face immediate delisting and cash-out.